Placeholder Banner

New Season of Biotech Podcast Builds Trust in Science

I AM BIO Podcast’s Spring 2022 Season Explores Water Conservation, Vaccine Technology, Alzheimer’s, and Addiction

March 22, 2022
Media Contact
Theresa Brady
202.962.9235

Washington, D.C.– The Biotechnology Innovation Organization (BIO) today premieres its new season of the I AM BIO podcast, which tells powerful stories across the biotechnology industry and how it heals, fuels, and feeds our world.

The season launches with an episode on water conservation, “Water Stress: Can We Avert a Looming Crisis?”, that focuses on technologies that address contaminants, overuse, and plastics.

“Right now, biotechnology breakthroughs are saving lives and our planet, and the I AM BIO podcast brings these powerful stories to life,” said BIO’s President and CEO Dr. Michelle McMurry-Heath, a physician-scientist and host of the I AM BIO podcast. “By sharing our industry’s amazing innovations – which address everything from climate change to Alzheimer’s and addiction – we can build greater public awareness of and trust in science.”

Additional episodes will cover:

podcast cover
  • How vaccines of all types helped bring us out of the COVID-19 pandemic and the growing potential of mRNA technology to treat and prevent diseases including cancer and other infectious diseases.
  • What makes carbon dioxide so dangerous and creative solutions to curb its impact.
  • Why Alzheimer’s is tricky to address and research in the pipeline.
  • Groundbreaking treatments to save people from overdosing and, ultimately, the disease of addiction.

 

Guests on the I AM BIO podcast are experts on the topics discussed and use data to explain the science in clear, engaging narratives. The new season will run for a total of 12 episodes – six this spring and six more beginning in September.

PR Daily recently named the I AM BIO podcast a finalist for its Social Media & Digital Awards in the podcast category.

Listen now on BIO’s website, Apple Podcasts, Google Podcasts, or Spotify.

Discover More
In an effort to secure medical supply chains and invest in the cures and treatment of the future, members of the House Ways and Means committee this week reintroduced major legislation that "ensures a healthier future for all Americans." BIO…
John Murphy, Chief Policy Officer at the Biotechnology Innovation Organization (BIO), released the following statement regarding reports of a proposed deal on a Covid-19 vaccine intellectual property rights waiver: “While we have seen the reported…
The following statement can be attributed to BIO’s President and CEO Dr. Michelle McMurry-Heath in response to the ongoing conflict in Ukraine and the organization’s efforts to help in humanitarian relief: “The conflict in Ukraine and violence…